Minute Insight: Best Buy Will Sell Dexcom CGM
The retail giant will sell the Dexcom G7 continuous glucose monitoring system to eligible customers through a new online platform.
You may also be interested in...
The medtech industry’s overall revenue growth has slowed down in the last year along with a decline in M&A activity and venture spending in the sector, according to a new report from Ernst & Young. The authors proposed that to overcome those challenges, medtech should invest in a new health care system that is digitized, connected, and intelligent.
Dexcom wins Health Canada approval to market its G7 CGM in Canada, following announcements of its ambitious R&D map to expand into metabolic health and new product plans for consumers and the diabetes markets at ADA.
In this first of a series of Exec Chats with leaders at major diabetes companies presenting at ADA’s Scientific Sessions 2023, CEO Kevin Sayer discusses Dexcom’s ambitious R&D map to expand into metabolic health and develop innovative new products for diabetes and consumer markets.